Both in Pharmaceuticals
Allarity Therapeutics vs Marker Therapeutics
Over the past year ALLR returned −18.1% and MRKR returned +2.4%; their daily moves had a correlation of 0.03.
ALLR −18.1% MRKR +2.4%Growth of $1, one year, split-adjusted
| Metric | ALLR | MRKR |
|---|---|---|
| Price | $1.13 | $0.9829 |
| Market cap | $18.0M | $16.4M |
| Today | +15.58% | +9.08% |
| 1 month | +13.0% | −7.3% |
| 6 months | −19.3% | −34.9% |
| Year to date | +4.6% | −34.0% |
| 1 year | −22.1% | −0.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 52.1× | 7.0× |
| Net cash | -$5.3M | $11.3M |
| Dividend yield | — | — |
| Volatility (60d) | 74.9% | 85.7% |
| Short % of float | 1.1% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).